These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17541036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
    Haklai R, Elad-Sfadia G, Egozi Y, Kloog Y.
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):89-96. PubMed ID: 17909812
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Sugita S, Enokida H, Yoshino H, Miyamoto K, Yonemori M, Sakaguchi T, Osako Y, Nakagawa M.
    Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel Ras antagonist blocks human melanoma growth.
    Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y, Wolff K.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14019-24. PubMed ID: 10570191
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Salirasib in the treatment of pancreatic cancer.
    Bustinza-Linares E, Kurzrock R, Tsimberidou AM.
    Future Oncol; 2010 Jun 15; 6(6):885-91. PubMed ID: 20528225
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y.
    Int J Cancer; 1999 Mar 15; 80(6):911-8. PubMed ID: 10074926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.